Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;5(6):766-9.
doi: 10.4161/19490976.2014.983762.

A surprising sweetener from enteropathogenic Escherichia coli

Jaclyn S Pearson  1 , Elizabeth L Hartland
Affiliations

A surprising sweetener from enteropathogenic Escherichia coli

Jaclyn S Pearson et al. Gut Microbes. 2014.

Abstract

Infections with enteropathogenic Escherichia coli (EPEC) are remarkably devoid of gut inflammation and necrotic damage compared to infections caused by invasive pathogens such as Salmonella and Shigella. Recently, we observed that EPEC blocks cell death using the type III secretion system (T3SS) effector NleB. NleB mediated post-translational modification of death domain containing adaptor proteins by the covalent attachment of N-acetylglucosamine (GlcNAc) to a conserved arginine in the death domain. N-linked glycosylation of arginine has not previously been reported in mammalian cell biology and the precise biochemistry of this modification is not yet defined. Although the addition of a single GlcNAc to arginine is a seemingly slight alteration, the impact of NleB is considerable as arginine in this location is critical for death domain interactions and death receptor induced apoptosis. Hence, by blocking cell death, NleB promotes enterocyte survival and thereby prolongs EPEC attachment to the gut epithelium.

Keywords: Fas ligand; T3SS; colitis; death domain; enteropathogenic E. coli; glycosyltransferase.

PubMed Disclaimer

References

    1. Wells L, Hart GW. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar. FEBS Lett 2003; 546:154-8; PMID:12829252; http://dx.doi.org/ 10.1016/S0014-5793(03)00641-0 - DOI - PubMed
    1. Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1999; 1473:4-8; PMID:10580125; http://dx.doi.org/ 10.1016/S0304-4165(99)00165-8 - DOI - PubMed
    1. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993; 3:97-130; PMID:8490246; http://dx.doi.org/ 10.1093/glycob/3.2.97 - DOI - PMC - PubMed
    1. Hoseki J, Ushioda R, Nagata K. Mechanism and components of endoplasmic reticulum-associated degradation. J Biochem 2010; 147:19-25; PMID:19923195; http://dx.doi.org/ 10.1093/jb/mvp194 - DOI - PubMed
    1. Roth J. Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. Chem Rev 2002; 102:285-303; PMID:11841244; http://dx.doi.org/ 10.1021/cr000423j - DOI - PubMed

Publication types

MeSH terms